Krikor Barsoumian, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Offices
- 2
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Barsoumian’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$162,339
Medicare paid this office $162,339 for 652 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 588 | $136,135 | $102 |
| New patient complete exam of visual system | 89 | $9,611 | $108 |
| Removal of cataract with insertion of prosthetic lens | 17 | $8,699 | $458 |
| Exam of visual field with extended testing | 16 | $850 | $50 |
Procedures Medicare counted
| Cataract surgery | 51 | More than 64% of doctors who do this |
Who their Medicare patients are
652 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 21% · Women 60% · Also on Medicaid 16% · Health risk score 1.15. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 35% · Coronary heart disease 29% · Chronic kidney disease 21% · Atrial fibrillation 20% · Heart failure 15% · Cancer 15% · Depression 12% · COPD 10% · Stroke 8% · Dementia 6%.
The office billed $393,175, Medicare allowed $238,336 and paid $162,339; for 1,523 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 652 | 1,523 | 77 | 1.15 | $393,175 | $162,339 |
| 2023 | 726 | 1,782 | 77 | 1.13 | $480,255 | $216,393 |
| 2022 | 803 | 1,974 | 77 | 1.05 | $553,940 | $233,869 |
| 2021 | 859 | 2,085 | 76 | 1.11 | $562,665 | $255,428 |
| 2020 | 734 | 1,702 | 76 | 1.23 | $470,940 | $192,709 |
| 2019 | 737 | 1,823 | 75 | 1.27 | $458,140 | $185,453 |
| 2018 | 814 | 2,035 | 76 | 1.20 | $520,285 | $195,317 |
| 2017 | 818 | 1,967 | 76 | 1.27 | $495,515 | $183,541 |
| 2016 | 764 | 1,876 | 76 | 1.17 | $416,111 | $183,018 |
| 2015 | 843 | 2,135 | 76 | 1.18 | $335,419 | $225,921 |
| 2014 | 849 | 2,208 | 76 | 1.14 | $312,609 | $213,011 |
| 2013 | 924 | 2,440 | 76 | 1.15 | $366,275 | $248,756 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Established patient complete exam of visual system | 650 | $163,866 | $112 |
| New patient complete exam of visual system | 119 | $14,971 | $126 |
| Removal of cataract with insertion of prosthetic lens | 23 | $13,776 | $510 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $5,256 | $309 |
| Ultrasound scan to determine eye length and lens power | 27 | $2,149 | $67 |
| Exam of visual field with extended testing | 30 | $1,773 | $59 |
| Imaging of retina | 19 | $1,098 | $39 |
2022: 7 services
| Established patient complete exam of visual system | 700 | $173,443 | $109 |
| Removal of cataract with insertion of prosthetic lens | 32 | $19,788 | $521 |
| New patient complete exam of visual system | 153 | $19,137 | $125 |
| Removal of recurring cataract in lens capsule using a laser | 24 | $7,607 | $293 |
| Ultrasound scan to determine eye length and lens power | 35 | $2,890 | $67 |
| Exam of visual field with extended testing | 30 | $1,671 | $56 |
| Imaging of retina | 18 | $653 | $34 |
2021: 10 services
| Established patient complete exam of visual system | 679 | $179,044 | $115 |
| New patient complete exam of visual system | 237 | $29,477 | $124 |
| Removal of cataract with insertion of prosthetic lens | 27 | $16,207 | $523 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $5,183 | $305 |
| Short return visit (20+ min) | 38 | $3,579 | $61 |
| Exam of visual field with extended testing | 43 | $2,760 | $63 |
| Ultrasound scan to determine eye length and lens power | 27 | $2,129 | $69 |
| New patient visit (30+ min) | 13 | $919 | $71 |
| Imaging of retina | 19 | $770 | $38 |
| Removal of foreign body in cornea using slit lamp | 11 | $752 | $63 |
2020: 8 services
| Established patient complete exam of visual system | 493 | $84,950 | $115 |
| Short return visit (20+ min) | 265 | $32,858 | $63 |
| New patient complete exam of visual system | 203 | $26,327 | $130 |
| Removal of cataract with insertion of prosthetic lens | 41 | $25,880 | $507 |
| Removal of recurring cataract in lens capsule using a laser | 13 | $3,847 | $296 |
| Ultrasound scan to determine eye length and lens power | 41 | $3,659 | $68 |
| Exam of visual field with extended testing | 23 | $1,373 | $60 |
| Imaging of retina | 15 | $781 | $41 |
2019: 12 services
| Short return visit (20+ min) | 404 | $61,738 | $64 |
| Established patient complete exam of visual system | 355 | $44,497 | $111 |
| Removal of cataract with insertion of prosthetic lens | 40 | $28,948 | $591 |
| New patient complete exam of visual system | 148 | $19,339 | $131 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $7,999 | $276 |
| Ultrasound scan to determine eye length and lens power | 42 | $3,617 | $67 |
| New patient visit (45+ min) | 19 | $2,239 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $1,709 | $114 |
| Exam of visual field with extended testing | 20 | $1,235 | $62 |
| Photography of the retina | 25 | $1,188 | $48 |
| Imaging of retina | 21 | $846 | $37 |
| Removal of eyelashes using forceps | 11 | $522 | $26 |
2018: 10 services
| Short return visit (20+ min) | 466 | $65,547 | $57 |
| Established patient complete exam of visual system | 388 | $42,517 | $101 |
| Removal of cataract with insertion of prosthetic lens | 48 | $36,727 | $592 |
| New patient complete exam of visual system | 91 | $9,741 | $107 |
| New patient visit (45+ min) | 72 | $9,336 | $130 |
| Removal of recurring cataract in lens capsule using a laser | 26 | $8,195 | $283 |
| Ultrasound scan to determine eye length and lens power | 48 | $4,052 | $66 |
| Exam of visual field with extended testing | 24 | $1,393 | $56 |
| Return visit (30+ min) | 13 | $822 | $63 |
| Imaging of retina | 17 | $711 | $37 |
2017: 9 services
| Short return visit (20+ min) | 438 | $59,656 | $56 |
| Established patient complete exam of visual system | 383 | $40,933 | $99 |
| Removal of cataract with insertion of prosthetic lens | 46 | $30,474 | $535 |
| New patient complete exam of visual system | 102 | $11,457 | $112 |
| New patient visit (45+ min) | 69 | $8,590 | $124 |
| Removal of recurring cataract in lens capsule using a laser | 21 | $6,463 | $269 |
| Return visit (30+ min) | 56 | $4,853 | $82 |
| Ultrasound scan to determine eye length and lens power | 46 | $4,540 | $78 |
| Exam of visual field with extended testing | 16 | $665 | $42 |
2016: 13 services
| Short return visit (20+ min) | 436 | $61,244 | $59 |
| Established patient complete exam of visual system | 364 | $40,567 | $103 |
| Removal of cataract with insertion of prosthetic lens | 50 | $34,316 | $572 |
| New patient complete exam of visual system | 94 | $11,369 | $121 |
| Removal of recurring cataract in lens capsule using a laser | 32 | $10,725 | $282 |
| Ultrasound scan to determine eye length and lens power | 46 | $4,498 | $82 |
| New patient visit (45+ min) | 26 | $3,595 | $138 |
| New patient visit (30+ min) | 20 | $1,834 | $92 |
| Return visit (30+ min) | 18 | $1,740 | $97 |
| Removal of eyelashes using forceps | 14 | $1,622 | $43 |
| Established patient problem focused exam of visual system | 22 | $1,594 | $72 |
| Exam of visual field with extended testing | 14 | $926 | $58 |
| Imaging of retina | 15 | $590 | $39 |
2015: 14 services
| Short return visit (20+ min) | 451 | $65,030 | $61 |
| Removal of cataract with insertion of prosthetic lens | 65 | $51,023 | $573 |
| Established patient complete exam of visual system | 418 | $43,566 | $102 |
| New patient complete exam of visual system | 152 | $18,605 | $122 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $9,849 | $290 |
| Ultrasound scan to determine eye length and lens power | 69 | $7,536 | $82 |
| Established patient problem focused exam of visual system | 36 | $2,710 | $71 |
| New patient visit (30+ min) | 27 | $2,496 | $92 |
| New patient visit (45+ min) | 18 | $2,394 | $133 |
| Removal of eyelashes using forceps | 16 | $2,228 | $46 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,090 | $161 |
| Return visit (30+ min) | 20 | $1,719 | $86 |
| Exam of visual field with extended testing | 23 | $1,430 | $62 |
| Imaging of retina | 27 | $1,272 | $42 |
2014: 14 services
| Short return visit (20+ min) | 474 | $72,573 | $60 |
| Established patient complete exam of visual system | 421 | $45,058 | $103 |
| Removal of cataract with insertion of prosthetic lens | 46 | $33,079 | $601 |
| New patient complete exam of visual system | 148 | $19,404 | $131 |
| Removal of recurring cataract in lens capsule using a laser | 32 | $11,568 | $297 |
| Ultrasound scan to determine eye length and lens power | 48 | $4,758 | $83 |
| Established patient problem focused exam of visual system | 30 | $2,527 | $82 |
| Removal of eyelashes using forceps | 22 | $2,433 | $45 |
| Return visit (30+ min) | 20 | $1,984 | $94 |
| New patient visit (45+ min) | 14 | $1,967 | $141 |
| New patient visit (30+ min) | 19 | $1,868 | $98 |
| Imaging of retina | 30 | $1,423 | $41 |
| Exam of visual field with extended testing | 17 | $1,032 | $57 |
| Removal of foreign body in cornea using slit lamp | 15 | $940 | $63 |
2013: 14 services
| Short return visit (20+ min) | 498 | $78,699 | $61 |
| Established patient complete exam of visual system | 465 | $48,065 | $100 |
| Removal of cataract with insertion of prosthetic lens | 66 | $47,863 | $606 |
| New patient complete exam of visual system | 121 | $14,875 | $123 |
| Removal of recurring cataract in lens capsule using a laser | 41 | $13,763 | $299 |
| Ultrasound scan to determine eye length and lens power | 67 | $6,849 | $86 |
| New patient visit (45+ min) | 28 | $3,922 | $140 |
| New patient visit (30+ min) | 38 | $3,491 | $92 |
| Removal of eyelashes using forceps | 27 | $3,079 | $42 |
| Return visit (30+ min) | 26 | $2,251 | $83 |
| Established patient problem focused exam of visual system | 23 | $1,981 | $83 |
| Imaging of retina | 41 | $1,613 | $38 |
| Exam of visual field with extended testing | 17 | $993 | $58 |
| Removal of foreign body in cornea using slit lamp | 15 | $960 | $60 |
Medicaid work
$5,130 in 2024
Medicaid paid $5,130 for 619 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 248 | $4,713 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 12 | $417 |
| GLAUCOMA PLAN OF CARE DOCD | 187 | $0 |
| IOP DOWN <15% OF PRE-SVC LVL | 172 | $0 |
| 2024 | 619 | 4 | 38 | $5,130 |
| 2023 | 1,401 | 4 | 52 | $9,430 |
| 2022 | 1,268 | 5 | 45 | $8,529 |
| 2021 | 1,117 | 4 | 49 | $9,434 |
| 2020 | 540 | 5 | 31 | $4,459 |
| 2019 | 500 | 3 | 38 | $7,050 |
| 2018 | 375 | 3 | 33 | $6,185 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 455 | $6,688 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 125 | $2,742 |
| GLAUCOMA PLAN OF CARE DOCD | 410 | $0 |
| IOP DOWN <15% OF PRE-SVC LVL | 411 | $0 |
2022
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 454 | $6,057 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 115 | $2,424 |
| DETERMINATION REFRACTIVE STATE | 13 | $48 |
| GLAUCOMA PLAN OF CARE DOCD | 343 | $0 |
| IOP DOWN <15% OF PRE-SVC LVL | 343 | $0 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 468 | $5,404 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 144 | $4,030 |
| GLAUCOMA PLAN OF CARE DOCD | 253 | $0 |
| IOP DOWN <15% OF PRE-SVC LVL | 252 | $0 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 130 | $2,103 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 33 | $1,247 |
| Short return visit (20+ min) | 103 | $1,109 |
| GLAUCOMA PLAN OF CARE DOCD | 137 | $0 |
| IOP DOWN <15% OF PRE-SVC LVL | 137 | $0 |
2019
| Short return visit (20+ min) | 383 | $3,576 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 104 | $3,041 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 13 | $432 |
2018
| Short return visit (20+ min) | 331 | $4,753 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 18 | $730 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 26 | $702 |
Drugs they prescribed that Part D paid
$253,798
Pharmacies billed $253,798 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,518) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
809 generic and fewer than 11 brand-name prescriptions · $253,798 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lumigan | 95 | $67,743 | $713 |
| Simbrinza | 62 | $25,717 | $415 |
| Restasis | 25 | $22,752 | $910 |
| Xiidra | 18 | $20,651 | $1,147 |
| Brimonidine | 112 | $16,891 | $151 |
See all 23 drugs
| Lumigan | 95 | $67,743 | $713 |
| Simbrinza | 62 | $25,717 | $415 |
| Restasis | 25 | $22,752 | $910 |
| Xiidra | 18 | $20,651 | $1,147 |
| Brimonidine | 112 | $16,891 | $151 |
| Alphagan P | 35 | $14,487 | $414 |
| Latanoprost | 378 | $6,466 | $17 |
| Travoprost | 32 | $5,296 | $165 |
| Cyclosporine | 20 | $4,285 | $214 |
| Methazolamide | 16 | $4,095 | $256 |
| Prednisolone Acetate | 53 | $2,693 | $51 |
| Azelastine | 71 | $2,099 | $30 |
| Dorzolamide-Timolol | 15 | $1,658 | $111 |
| Moxifloxacin | 40 | $1,201 | $30 |
| Timolol Maleate | 44 | $1,176 | $27 |
| Dorzolamide-Timolol | 62 | $1,007 | $16 |
| Neomycin-Polymyxin-Dexameth | 98 | $928 | $9 |
| Ofloxacin | 51 | $830 | $16 |
| Brimonidine Tartrate-Timolol | 11 | $711 | $65 |
| Ketorolac Tromethamine | 45 | $550 | $12 |
| Ciprofloxacin | 24 | $426 | $18 |
| Dorzolamide | 17 | $402 | $24 |
| Erythromycin | 30 | $273 | $9 |
Year by year
| 2024 | 1,518 | 413 | 0% (0) | None | $253,798 |
| 2023 | 1,585 | 379 | None | 54% | $318,946 |
| 2022 | 1,725 | 395 | 0% (0) | 52% | $292,924 |
| 2021 | 1,850 | 438 | None | 52% | $302,179 |
| 2020 | 2,175 | 494 | None | 52% | $356,443 |
| 2019 | 2,249 | 575 | None | 48% | $379,108 |
| 2018 | 2,391 | 572 | None | 52% | $367,024 |
| 2017 | 2,310 | 497 | None | 53% | $328,709 |
| 2016 | 2,294 | 517 | None | 57% | $307,655 |
| 2015 | 2,136 | 490 | None | 59% | $261,466 |
| 2014 | 2,128 | 452 | 1% (11) | 62% | $254,832 |
| 2013 | 1,934 | 425 | None | 64% | $209,887 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Lumigan | 113 | $71,373 | $632 |
| Alphagan P | 103 | $54,872 | $533 |
| Restasis | 42 | $39,958 | $951 |
| Simbrinza | 73 | $22,678 | $311 |
| Xiidra | 15 | $19,787 | $1,319 |
| Latanoprost | 465 | $12,686 | $27 |
| Combigan | 17 | $8,345 | $491 |
| Travoprost | 32 | $7,855 | $245 |
| Xalatan | 12 | $5,571 | $464 |
| Brimonidine | 53 | $3,746 | $71 |
| Prednisolone Acetate | 47 | $3,466 | $74 |
| Ketorolac Tromethamine | 51 | $2,906 | $57 |
| Dorzolamide-Timolol | 74 | $2,665 | $36 |
| Dorzolamide-Timolol | 15 | $1,792 | $119 |
| Trifluridine | 11 | $1,675 | $152 |
| Ofloxacin | 47 | $1,423 | $30 |
| Timolol Maleate | 46 | $1,264 | $27 |
| Dorzolamide | 29 | $1,216 | $42 |
| Neomycin-Polymyxin-Dexameth | 83 | $1,215 | $15 |
| Moxifloxacin | 11 | $860 | $78 |
| Azelastine | 19 | $700 | $37 |
| Ciprofloxacin | 21 | $627 | $30 |
| Erythromycin | 31 | $402 | $13 |
| Olopatadine | 11 | $366 | $33 |
2022: 27 drugs
| Lumigan | 146 | $71,632 | $491 |
| Restasis | 53 | $46,006 | $868 |
| Alphagan P | 76 | $38,168 | $502 |
| Xiidra | 17 | $17,999 | $1,059 |
| Simbrinza | 64 | $13,980 | $218 |
| Latanoprost | 491 | $10,826 | $22 |
| Travoprost | 32 | $7,469 | $233 |
| Methazolamide | 16 | $5,756 | $360 |
| Xalatan | 13 | $5,449 | $419 |
| Rocklatan | 11 | $3,683 | $335 |
| Ketorolac Tromethamine | 61 | $3,673 | $60 |
| Zioptan | 15 | $3,385 | $226 |
| Dorzolamide-Timolol | 72 | $2,333 | $32 |
| Olopatadine | 34 | $2,320 | $68 |
| Dorzolamide-Timolol | 16 | $2,169 | $136 |
| Flarex | 13 | $2,003 | $154 |
| Prednisolone Acetate | 27 | $1,903 | $70 |
| Neomycin-Polymyxin-Dexameth | 107 | $1,460 | $14 |
| Ofloxacin | 54 | $1,135 | $21 |
| Dorzolamide | 29 | $1,078 | $37 |
| Brimonidine | 40 | $1,012 | $25 |
| Timolol Maleate | 43 | $990 | $23 |
| Erythromycin | 56 | $832 | $15 |
| Moxifloxacin | 14 | $693 | $50 |
| Azelastine | 13 | $661 | $51 |
| Ciprofloxacin | 11 | $269 | $24 |
| Tobramycin | 17 | $236 | $14 |
2021: 27 drugs
| Restasis | 76 | $70,437 | $927 |
| Lumigan | 140 | $59,423 | $424 |
| Alphagan P | 99 | $31,139 | $315 |
| Xiidra | 28 | $22,049 | $787 |
| Latanoprost | 498 | $11,376 | $23 |
| Travoprost | 32 | $11,211 | $350 |
| Simbrinza | 45 | $10,167 | $226 |
| Azopt | 25 | $9,171 | $367 |
| Rocklatan | 12 | $6,078 | $506 |
| Xalatan | 14 | $5,070 | $362 |
| Olopatadine | 68 | $4,265 | $63 |
| Methazolamide | 13 | $2,833 | $218 |
| Dorzolamide-Timolol | 18 | $2,388 | $133 |
| Prednisolone Acetate | 49 | $2,292 | $47 |
| Dorzolamide-Timolol | 53 | $2,192 | $41 |
| Azelastine | 31 | $1,690 | $55 |
| Ketorolac Tromethamine | 67 | $1,689 | $25 |
| Dorzolamide | 35 | $1,535 | $44 |
| Neomycin-Polymyxin-Dexameth | 97 | $1,426 | $15 |
| Timolol Maleate | 64 | $1,363 | $21 |
| Ofloxacin | 72 | $999 | $14 |
| Erythromycin | 58 | $959 | $17 |
| Brimonidine | 32 | $796 | $25 |
| Moxifloxacin | 15 | $509 | $34 |
| Ciprofloxacin | 19 | $297 | $16 |
| Tobramycin | 16 | $227 | $14 |
| Atorvastatin | 18 | $113 | $6 |
2020: 34 drugs
| Restasis | 104 | $81,043 | $779 |
| Lumigan | 161 | $72,667 | $451 |
| Alphagan P | 140 | $39,576 | $283 |
| Azopt | 37 | $15,141 | $409 |
| Xiidra | 15 | $13,623 | $908 |
| Simbrinza | 72 | $13,187 | $183 |
| Pazeo | 55 | $11,595 | $211 |
| Restasis Multidose | 11 | $9,076 | $825 |
| Travoprost | 35 | $8,562 | $245 |
| Latanoprost | 478 | $7,809 | $16 |
| Travatan Z | 19 | $6,811 | $358 |
| Ilevro | 12 | $6,494 | $541 |
| Olopatadine | 116 | $4,485 | $39 |
| Combigan | 16 | $4,046 | $253 |
| Rocklatan | 13 | $3,933 | $303 |
| Prednisolone Acetate | 84 | $3,231 | $38 |
| Cosopt Pf | 15 | $2,461 | $164 |
| Bimatoprost | 11 | $1,928 | $175 |
| Trifluridine | 12 | $1,918 | $160 |
| Ketorolac Tromethamine | 71 | $1,783 | $25 |
| Brimonidine | 33 | $1,731 | $52 |
| Dorzolamide-Timolol | 46 | $1,729 | $38 |
| Dorzolamide | 37 | $1,663 | $45 |
| Ofloxacin | 105 | $1,492 | $14 |
| Neomycin-Polymyxin-Dexameth | 86 | $1,365 | $16 |
| Moxifloxacin | 18 | $1,164 | $65 |
| Azelastine | 35 | $1,028 | $29 |
| Erythromycin | 62 | $944 | $15 |
| Timolol Maleate | 45 | $610 | $14 |
| Acyclovir | 14 | $296 | $21 |
| Ciprofloxacin | 15 | $178 | $12 |
| Tobramycin | 18 | $158 | $9 |
| Prednisone | 11 | $108 | $10 |
| Atorvastatin | 15 | $69 | $5 |
2019: 31 drugs
| Restasis | 135 | $104,703 | $776 |
| Lumigan | 188 | $73,184 | $389 |
| Alphagan P | 105 | $39,814 | $379 |
| Travatan Z | 57 | $18,941 | $332 |
| Azopt | 31 | $12,264 | $396 |
| Ilevro | 31 | $11,765 | $380 |
| Simbrinza | 61 | $10,922 | $179 |
| Pazeo | 50 | $9,862 | $197 |
| Latanoprost | 417 | $7,327 | $18 |
| Combigan | 23 | $6,176 | $269 |
| Cosopt Pf | 27 | $5,421 | $201 |
| Prednisolone Acetate | 93 | $4,356 | $47 |
| Olopatadine | 75 | $3,926 | $52 |
| Dorzolamide-Timolol | 51 | $2,811 | $55 |
| Brimonidine | 20 | $2,454 | $123 |
| Neomycin-Polymyxin-Dexameth | 118 | $1,845 | $16 |
| Bromfenac | 11 | $1,840 | $167 |
| Azelastine | 52 | $1,797 | $35 |
| Trifluridine | 11 | $1,730 | $157 |
| Ofloxacin | 105 | $1,664 | $16 |
| Ketorolac Tromethamine | 95 | $1,600 | $17 |
| Erythromycin | 91 | $1,517 | $17 |
| Epinastine | 26 | $1,432 | $55 |
| Fluorometholone | 15 | $1,343 | $90 |
| Dorzolamide | 34 | $833 | $25 |
| Moxifloxacin | 14 | $703 | $50 |
| Acyclovir | 20 | $510 | $26 |
| Timolol Maleate | 37 | $408 | $11 |
| Prednisone | 19 | $188 | $10 |
| Tobramycin | 17 | $122 | $7 |
| Atorvastatin | 12 | $110 | $9 |
2018: 31 drugs
| Restasis | 170 | $107,831 | $634 |
| Lumigan | 199 | $59,074 | $297 |
| Alphagan P | 102 | $32,660 | $320 |
| Travatan Z | 71 | $18,123 | $255 |
| Ilevro | 30 | $11,776 | $393 |
| Azopt | 32 | $11,543 | $361 |
| Xiidra | 12 | $11,040 | $920 |
| Simbrinza | 63 | $10,791 | $171 |
| Pazeo | 41 | $8,208 | $200 |
| Latanoprost | 450 | $7,866 | $17 |
| Prednisolone Acetate | 132 | $7,006 | $53 |
| Cosopt Pf | 32 | $5,910 | $185 |
| Brimonidine | 30 | $4,706 | $157 |
| Bepreve | 15 | $4,408 | $294 |
| Combigan | 26 | $4,203 | $162 |
| Nevanac | 14 | $3,989 | $285 |
| Olopatadine | 64 | $3,661 | $57 |
| Epinastine | 50 | $3,051 | $61 |
| Azelastine | 46 | $2,112 | $46 |
| Neomycin-Polymyxin-Dexameth | 129 | $2,069 | $16 |
| Ketorolac Tromethamine | 93 | $1,592 | $17 |
| Dorzolamide-Timolol | 67 | $1,584 | $24 |
| Trifluridine | 11 | $1,473 | $134 |
| Ofloxacin | 73 | $1,078 | $15 |
| Erythromycin | 76 | $1,075 | $14 |
| Dorzolamide | 47 | $982 | $21 |
| Timolol Maleate | 52 | $466 | $9 |
| Acyclovir | 25 | $347 | $14 |
| Tobramycin | 22 | $237 | $11 |
| Ciprofloxacin | 19 | $189 | $10 |
| Atorvastatin | 19 | $124 | $7 |
2017: 31 drugs
| Restasis | 173 | $101,370 | $586 |
| Lumigan | 236 | $60,685 | $257 |
| Alphagan P | 135 | $35,208 | $261 |
| Travatan Z | 72 | $17,869 | $248 |
| Azopt | 27 | $8,145 | $302 |
| Prednisolone Acetate | 134 | $7,608 | $57 |
| Latanoprost | 438 | $7,236 | $17 |
| Ilevro | 15 | $5,839 | $389 |
| Pazeo | 28 | $5,293 | $189 |
| Azasite | 19 | $4,689 | $247 |
| Pataday | 22 | $3,889 | $177 |
| Combigan | 24 | $3,844 | $160 |
| Brimonidine | 29 | $3,786 | $131 |
| Bepreve | 13 | $3,425 | $263 |
| Nevanac | 12 | $3,169 | $264 |
| Olopatadine | 37 | $2,716 | $73 |
| Besivance | 16 | $2,425 | $152 |
| Dorzolamide-Timolol | 93 | $2,323 | $25 |
| Epinastine | 39 | $2,049 | $53 |
| Azelastine | 41 | $1,839 | $45 |
| Ofloxacin | 105 | $1,742 | $17 |
| Dorzolamide | 81 | $1,735 | $21 |
| Erythromycin | 88 | $1,281 | $15 |
| Neomycin-Polymyxin-Dexameth | 90 | $1,239 | $14 |
| Ketorolac Tromethamine | 64 | $1,090 | $17 |
| Tobramycin-Dexamethasone | 12 | $1,086 | $90 |
| Ciprofloxacin | 26 | $267 | $10 |
| Timolol Maleate | 27 | $229 | $8 |
| Tobramycin | 24 | $197 | $8 |
| Acyclovir | 13 | $196 | $15 |
| Diclofenac | 12 | $165 | $14 |
2016: 32 drugs
| Restasis | 222 | $102,793 | $463 |
| Lumigan | 240 | $52,126 | $217 |
| Alphagan P | 117 | $25,185 | $215 |
| Travatan Z | 81 | $19,117 | $236 |
| Pataday | 68 | $12,268 | $180 |
| Azopt | 31 | $11,191 | $361 |
| Latanoprost | 410 | $6,657 | $16 |
| Prednisolone Acetate | 110 | $6,015 | $55 |
| Pazeo | 32 | $5,755 | $180 |
| Zioptan | 17 | $4,612 | $271 |
| Brimonidine | 42 | $3,807 | $91 |
| Ilevro | 13 | $2,964 | $228 |
| Combigan | 21 | $2,888 | $138 |
| Bepreve | 12 | $2,846 | $237 |
| Epinastine | 36 | $2,164 | $60 |
| Vigamox | 13 | $1,972 | $152 |
| Dorzolamide | 76 | $1,775 | $23 |
| Apraclonidine | 13 | $1,726 | $133 |
| Ketorolac Tromethamine | 96 | $1,706 | $18 |
| Trifluridine | 13 | $1,690 | $130 |
| Ofloxacin | 92 | $1,646 | $18 |
| Olopatadine | 29 | $1,624 | $56 |
| Dorzolamide-Timolol | 68 | $1,525 | $22 |
| Tobramycin-Dexamethasone | 11 | $1,201 | $109 |
| Azelastine | 24 | $1,141 | $48 |
| Timolol Maleate | 34 | $1,131 | $33 |
| Erythromycin | 72 | $1,079 | $15 |
| Neomycin-Polymyxin-Dexameth | 61 | $989 | $16 |
| Acyclovir | 21 | $452 | $22 |
| Diclofenac | 18 | $217 | $12 |
| Tobramycin | 24 | $188 | $8 |
| Ciprofloxacin | 23 | $147 | $6 |
2015: 30 drugs
| Restasis | 208 | $84,259 | $405 |
| Lumigan | 200 | $35,986 | $180 |
| Alphagan P | 111 | $20,519 | $185 |
| Travatan Z | 96 | $17,000 | $177 |
| Pataday | 90 | $15,812 | $176 |
| Azopt | 43 | $13,386 | $311 |
| Prednisolone Acetate | 98 | $6,542 | $67 |
| Patanol | 26 | $6,226 | $239 |
| Latanoprost | 374 | $5,580 | $15 |
| Bepreve | 23 | $4,966 | $216 |
| Lastacaft | 20 | $3,536 | $177 |
| Nevanac | 15 | $3,425 | $228 |
| Zioptan | 14 | $2,810 | $201 |
| Combigan | 18 | $2,333 | $130 |
| Lotemax | 12 | $1,890 | $158 |
| Azelastine | 23 | $1,639 | $71 |
| Dorzolamide-Timolol | 64 | $1,545 | $24 |
| Ketorolac Tromethamine | 81 | $1,539 | $19 |
| Epinastine | 25 | $1,532 | $61 |
| Dorzolamide | 59 | $1,341 | $23 |
| Erythromycin | 83 | $1,199 | $14 |
| Brimonidine | 40 | $1,197 | $30 |
| Tobramycin-Dexamethasone | 11 | $1,134 | $103 |
| Ofloxacin | 59 | $1,109 | $19 |
| Timolol Maleate | 24 | $1,095 | $46 |
| Neomycin-Polymyxin-Dexameth | 62 | $1,062 | $17 |
| Levobunolol | 12 | $351 | $29 |
| Ciprofloxacin | 29 | $274 | $9 |
| Diclofenac | 17 | $240 | $14 |
| Tobramycin | 21 | $172 | $8 |
2014: 34 drugs
| Restasis | 218 | $78,860 | $362 |
| Lumigan | 171 | $31,145 | $182 |
| Pataday | 121 | $19,313 | $160 |
| Travatan Z | 128 | $19,128 | $149 |
| Alphagan P | 89 | $15,004 | $169 |
| Azopt | 51 | $9,695 | $190 |
| Prednisolone Acetate | 138 | $9,307 | $67 |
| Bepreve | 23 | $6,956 | $302 |
| Patanol | 42 | $6,918 | $165 |
| Latanoprost | 393 | $6,028 | $15 |
| Lotemax | 28 | $4,685 | $167 |
| Prolensa | 19 | $3,735 | $197 |
| Nevanac | 16 | $2,814 | $176 |
| Zioptan | 16 | $2,680 | $167 |
| Vigamox | 16 | $2,153 | $135 |
| Tobramycin-Dexamethasone | 21 | $1,974 | $94 |
| Lastacaft | 11 | $1,546 | $141 |
| Trifluridine | 11 | $1,525 | $139 |
| Dorzolamide | 52 | $1,388 | $27 |
| Epinastine | 21 | $1,325 | $63 |
| Brimonidine | 38 | $1,205 | $32 |
| Azelastine | 14 | $1,047 | $75 |
| Gatifloxacin | 11 | $1,039 | $94 |
| Dorzolamide-Timolol | 27 | $965 | $36 |
| Erythromycin | 56 | $886 | $16 |
| Ofloxacin | 71 | $821 | $12 |
| Timolol Maleate | 28 | $776 | $28 |
| Diclofenac | 46 | $680 | $15 |
| Neomycin-Polymyxin-Dexameth | 34 | $596 | $18 |
| Ketorolac Tromethamine | 20 | $468 | $23 |
| Levobunolol | 12 | $421 | $35 |
| Acyclovir | 14 | $273 | $19 |
| Tobramycin | 30 | $265 | $9 |
| Hydrocodone-Acetaminophen | 11 | $69 | $6 |
2013: 25 drugs
| Restasis | 201 | $63,469 | $316 |
| Pataday | 198 | $27,594 | $139 |
| Lumigan | 150 | $27,164 | $181 |
| Azopt | 87 | $13,923 | $160 |
| Travatan Z | 93 | $12,317 | $132 |
| Alphagan P | 68 | $12,188 | $179 |
| Latanoprost | 369 | $6,213 | $17 |
| Patanol | 34 | $4,735 | $139 |
| Bepreve | 17 | $3,734 | $220 |
| Lotemax | 25 | $3,674 | $147 |
| Nevanac | 22 | $3,352 | $152 |
| Prednisolone Acetate | 105 | $2,390 | $23 |
| Lastacaft | 14 | $2,058 | $147 |
| Dorzolamide | 66 | $1,889 | $29 |
| Zioptan | 13 | $1,730 | $133 |
| Tobramycin-Dexamethasone | 21 | $1,672 | $80 |
| Brimonidine | 29 | $968 | $33 |
| Dorzolamide-Timolol | 17 | $817 | $48 |
| Erythromycin | 43 | $722 | $17 |
| Diclofenac | 38 | $646 | $17 |
| Ofloxacin | 59 | $516 | $9 |
| Timolol Maleate | 30 | $503 | $17 |
| Neomycin-Polymyxin-Dexameth | 26 | $500 | $19 |
| Tobramycin | 33 | $364 | $11 |
| Acyclovir | 19 | $360 | $19 |
Money from drug and device companies
$1,041 in 2025
| 2025 | 6 | 28 | None | $1,041 |
| 2024 | 5 | 28 | None | $1,097 |
| 2023 | 7 | 30 | None | $1,085 |
| 2022 | 11 | 31 | None | $649 |
| 2021 | 5 | 9 | None | $291 |
| 2020 | 4 | 18 | None | $282 |
| 2019 | 7 | 26 | None | $1,129 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Lumigan | $353 | 13 payments
|
| Alcon Vision | Tryptyr | $347 | 7 payments
|
| Sun Pharmaceutical Industries | Cequa | $153 | 2 payments
|
| Amgen | Tepezza | $94 | 3 payments
|
| Biotissue Holdings | None | $72 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $22 | 1 payment
|
See all 28 published payments
| Alcon Vision | Meals · 2025-12-09 | Tryptyr | $31 |
| Amgen | Meals · 2025-11-24 | Tepezza | $31 |
| Alcon Vision | Meals · 2025-11-18 | Tryptyr | $6 |
| Abbvie | Meals · 2025-11-13 | Lumigan | $35 |
| Sun Pharmaceutical Industries | Meals · 2025-10-20 | Cequa | $29 |
| Abbvie | Meals · 2025-10-10 | Lumigan | $35 |
| Alcon Vision | Meals · 2025-10-07 | Tryptyr | $9 |
| Abbvie | Meals · 2025-08-25 | Lumigan | $32 |
| Alcon Vision | Meals · 2025-08-08 | Tryptyr | $34 |
| Abbvie | Meals · 2025-08-05 | Lumigan | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-07-30 | Cequa | $124 |
| Amgen | Meals · 2025-07-24 | Tepezza | $32 |
| Alcon Vision | Meals · 2025-07-23 | Tryptyr | $122 |
| Abbvie | Meals · 2025-07-08 | Lumigan | $33 |
| Alcon Vision | Meals · 2025-06-26 | Rhopressa | $125 |
| Abbvie | Meals · 2025-06-17 | Lumigan | $35 |
| Abbvie | Meals · 2025-05-19 | Lumigan | $35 |
| Biotissue Holdings | Meals · 2025-04-29 | None | $47 |
| Amgen | Meals · 2025-04-28 | Tepezza | $31 |
| Biotissue Holdings | Meals · 2025-04-10 | None | $25 |
| Abbvie | Meals · 2025-04-08 | Lumigan | $35 |
| Abbvie | Meals · 2025-03-18 | Lumigan | $33 |
| Oyster Point Pharma | Meals · 2025-02-25 | Tyrvaya | $22 |
| Abbvie | Meals · 2025-02-24 | Lumigan | $33 |
| Abbvie | Meals · 2025-02-24 | Lumigan | $1 |
| Abbvie | Meals · 2025-01-23 | Lumigan | $1 |
| Abbvie | Meals · 2025-01-23 | Lumigan | $30 |
| Alcon Vision | Meals · 2025-01-07 | Rocklatan | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,097
| Amgen | Tepezza | $400 | 13 payments
|
| Bausch & Lomb Americas | Vyzulta | $279 | 8 payments
|
| Alcon Vision | Rocklatan | $189 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $140 | 1 payment
|
| Abbvie | Lumigan | $88 | 3 payments
|
2023: $1,085
| Oyster Point Pharma | Tyrvaya | $356 | 11 payments
|
| Horizon Therapeutics plc | Tepezza | $299 | 4 payments
|
| Novartis Pharmaceuticals | Xiidra | $153 | 7 payments
|
| Bausch & Lomb Americas | Miebo | $151 | 3 payments
|
| AbbVie | Lumigan | $69 | 3 payments
|
| Glaukos | Photrexa Cross-Linking Kit | $32 | 1 payment
|
| Alcon Vision | Rocklatan | $24 | 1 payment
|
2022: $649
| Novartis Pharmaceuticals | Xiidra | $199 | 12 payments
|
| Oyster Point Pharma | Tyrvaya | $196 | 5 payments
|
| Horizon Therapeutics plc | Tepezza | $77 | 4 payments
|
| Kala Pharmaceuticals | Inveltys | $59 | 3 payments
|
| Abbvie | Vuity | $21 | 1 payment
|
| Apellis Pharmaceuticals | None | $18 | 1 payment
|
| Glaukos | Istent Inject W | $17 | 1 payment
|
| Eyevance Pharmaceuticals | Tobradex St | $17 | 1 payment
|
| Allergan | Vuity | $15 | 1 payment
|
| Thea Pharma | None | $15 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $14 | 1 payment
|
2021: $291
| Kala Pharmaceuticals | Eysuvis | $124 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $71 | 3 payments
|
| Allergan | Durysta | $48 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $29 | 1 payment
|
| Tissuetech | Prokera | $20 | 1 payment
|
2020: $282
| Allergan | Lumigan | $167 | 12 payments
|
| Sun Pharmaceutical Industries | Xelpros | $40 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $40 | 2 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $35 | 2 payments
|
2019: $1,129
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $466 | 11 payments
|
| Aerie Pharmaceuticals | Rhopressa | $287 | 5 payments
|
| Genentech USA | Lucentis | $125 | 1 payment
|
| AbbVie | Humira | $125 | 1 payment
|
| Allergan | Alphagan P | $58 | 4 payments
|
| Sun Pharmaceutical Industries | Cequa | $40 | 2 payments
|
| Optos | P200dtx | $29 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 23.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1649296021
- Licence
- CA AB350330
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 2440 Samaritan Dr, Suite 3, San Jose, CA, 95124
- NPI first listed
- 2006-07-15
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.